Krystal Biotech, Inc. KRYS Other long-term liabilities
Other long-term liabilities at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s other long-term liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s other long-term liabilities?
- Krystal Biotech, Inc. (KRYS) reported other long-term liabilities of $1.44M in Q1 2026.
- How has Krystal Biotech, Inc.'s other long-term liabilities changed year-over-year?
- Krystal Biotech, Inc.'s other long-term liabilities increased by 168.7% year-over-year, from $534K to $1.44M.